BioPharma

03 August, 2026 | Monday | Expert Insight

Advancing Freeze-to-Store Workflows for the Next Era of Biopharmaceutical Manufacturing

As biologics, biosimilars, and advanced cell and gene therapies continue to reshape the Asia-Pacific biopharmaceutical landscape, manufacturers are under increasing pressure to enhance cold ch...

Lab

05 August, 2026 | Wednesday | Analysis

10 Bioprocessing Bottlenecks and How APAC Plants Are Clearing Them

How this list was built Ten bottlenecks were identified from facility interviews, technical sessions at regional bioprocessing conferences and published case studies. Each entry pairs a constraint with...

BioTech

04 August, 2026 | Tuesday | Interaction

From Market Access to Long-Term Growth: Rethinking Biopharma Expansion in APAC

BioPharma APAC speaks with Girisan Kariangal, Regional Vice President – Business Development & Alliance Management, Menarini Asia-Pacific, on the evolving opportunities and challenges of expanding acr...

Contract Services

05 August, 2026 | Wednesday | News

Enzene Launches NeX™ to Enable Local Biologics Manufacturing Worldwide

Enzene, a leading global continuously innovative development and manufacturing organization (CIDMO™), announced the launch of NeX™, a transformative end-to-end partnership model that enables governm...

Consumer Health

28 July, 2026 | Tuesday | News

Roche Secures US FDA Clearance for PCR Test Detecting Bacterial Vaginosis and Candida Vaginitis

The new PCR test uses clinician-collected or clinician-instructed, self-collected vaginal swab specimens to simultaneously detect organisms associated with Bacterial vaginosis (BV) and Candida ...

Medtech

05 August, 2026 | Wednesday | News

MARS Bioimaging Secures First Clinical Sale of Portable Photon-Counting CT System

Christchurch-based Reform Radiology becomes inaugural clinical customer as New Zealand-developed photon-counting CT technology enters routine clinical practice Advanced photon-counting CT technology del...

Cell & Gene

05 August, 2026 | Wednesday | News

Vaxcellbio Partners with Myellama to Advance Next-Generation NK Cell Therapy for Multiple Myeloma

 Vaxcellbio (CEO Je-Jung Lee, MD, PhD), a leading immuno-oncology company, announced today that it has signed a strategic Memorandum of Understanding (MOU) with Canadian biotechnology company Myellama to j...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close